Cape Cod Five Cents Savings Bank lifted its position in Chemed Corp. (NYSE:CHE) by 8.3% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,966 shares of the company’s stock after purchasing an additional 455 shares during the quarter. Cape Cod Five Cents Savings Bank’s holdings in Chemed Corp. were worth $1,206,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Vanguard Group Inc. boosted its position in shares of Chemed Corp. by 1.9% in the 2nd quarter. Vanguard Group Inc. now owns 1,830,711 shares of the company’s stock valued at $374,435,000 after purchasing an additional 34,938 shares during the period. Acadian Asset Management LLC lifted its position in Chemed Corp. by 1.3% during the 2nd quarter. Acadian Asset Management LLC now owns 579,170 shares of the company’s stock worth $118,454,000 after acquiring an additional 7,636 shares during the period. State Street Corp lifted its position in Chemed Corp. by 1.8% during the 2nd quarter. State Street Corp now owns 453,605 shares of the company’s stock worth $92,782,000 after acquiring an additional 8,238 shares during the period. Voya Investment Management LLC lifted its position in Chemed Corp. by 39.7% during the 2nd quarter. Voya Investment Management LLC now owns 214,764 shares of the company’s stock worth $43,926,000 after acquiring an additional 61,056 shares during the period. Finally, Thrivent Financial For Lutherans lifted its position in Chemed Corp. by 0.3% during the 2nd quarter. Thrivent Financial For Lutherans now owns 171,350 shares of the company’s stock worth $35,046,000 after acquiring an additional 490 shares during the period. 97.29% of the stock is owned by hedge funds and other institutional investors.
CHE has been the subject of a number of recent research reports. TheStreet cut Chemed Corp. from a “b+” rating to a “c+” rating in a research report on Tuesday, July 25th. Oppenheimer Holdings, Inc. raised their price target on Chemed Corp. from $200.00 to $220.00 and gave the company an “outperform” rating in a report on Thursday, July 27th. Zacks Investment Research raised Chemed Corp. from a “hold” rating to a “buy” rating and set a $226.00 price target for the company in a report on Friday, July 28th. Royal Bank Of Canada reissued a “hold” rating and issued a $209.00 price target on shares of Chemed Corp. in a report on Monday, July 31st. Finally, BidaskClub cut Chemed Corp. from a “buy” rating to a “hold” rating in a report on Wednesday, August 2nd. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $236.00.
TRADEMARK VIOLATION WARNING: This piece was first posted by Community Financial News and is the property of of Community Financial News. If you are accessing this piece on another website, it was copied illegally and reposted in violation of international trademark and copyright laws. The correct version of this piece can be viewed at https://www.com-unik.info/2017/11/06/chemed-corp-che-shares-bought-by-cape-cod-five-cents-savings-bank.html.
In other news, VP Naomi C. Dallob sold 750 shares of the firm’s stock in a transaction on Tuesday, October 31st. The stock was sold at an average price of $222.09, for a total transaction of $166,567.50. Following the sale, the vice president now owns 9,097 shares in the company, valued at $2,020,352.73. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Kevin J. Mcnamara sold 10,000 shares of the firm’s stock in a transaction on Tuesday, October 31st. The stock was sold at an average price of $223.42, for a total value of $2,234,200.00. Following the sale, the chief executive officer now owns 170,016 shares in the company, valued at approximately $37,984,974.72. The disclosure for this sale can be found here. Insiders have sold 13,250 shares of company stock worth $2,927,418 in the last 90 days. Insiders own 4.90% of the company’s stock.
Chemed Corp. (CHE) traded down $4.81 during midday trading on Monday, reaching $230.20. The company had a trading volume of 27,965 shares, compared to its average volume of 96,024. The stock has a market capitalization of $3,752.17, a PE ratio of 28.94, a P/E/G ratio of 4.97 and a beta of 1.14. The company has a current ratio of 0.50, a quick ratio of 0.48 and a debt-to-equity ratio of 0.15.
Chemed Corp. (NYSE:CHE) last released its quarterly earnings data on Thursday, October 26th. The company reported $2.15 earnings per share for the quarter, beating the consensus estimate of $2.00 by $0.15. The firm had revenue of $417.40 million during the quarter, compared to the consensus estimate of $414.34 million. Chemed Corp. had a return on equity of 27.69% and a net margin of 4.62%. Chemed Corp.’s quarterly revenue was up 6.3% on a year-over-year basis. During the same period last year, the business posted $1.73 EPS. equities research analysts forecast that Chemed Corp. will post 4.73 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 4th. Stockholders of record on Monday, November 13th will be issued a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a dividend yield of 0.49%. The ex-dividend date of this dividend is Friday, November 10th. Chemed Corp.’s dividend payout ratio (DPR) is 24.89%.
Chemed Corp. Company Profile
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corp. (NYSE:CHE).
What are top analysts saying about Chemed Corp.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Chemed Corp. and related companies.